Skip to main content

$0.038 0.005 (15.15%)

High

$0.04

Low

$0.03

Trades

55

Turnover

$121,565

Volume

3,767,585
30 June 2023 at 4:10pm
Register to track RSH and receive email alerts.
Subject
RSH Ann: wheezo Registered and Approved for Sale in the UK Market

RSH Ann: ADR: Adherium responds to Respiri announcement

RSH Ann: RPM CPT Reimbursement & response to statements made by ADR

RSH Ann: wheezo production update &Chief Commercial Offer appointment

RSH Ann: Replacement Bidders Statement

RSH Ann: 1st Supplementary Bidder's Statement(marked up replacement

RSH Ann: Major Shareholder Update

RSH Ann: Notice under section 633(4) Corps Act 2001

RSH Ann: ADR: Adherium Directors' Statement re Takeover

RSH Ann: Proposed issue of Securities - RSH

RSH Ann: Notice of initial substantial holder for ADR

RSH Ann: ADR: Adherium response to Respiri announcement

RSH Ann: Bidder's Statement

RSH Ann: Appendix 4C - quarterly

RSH Ann: Respiri Partnership with TerryWhite Chemmart Group

RSH Ann: Respiratory Physician led programme launching in Australia

RSH Ann: Strategic Advisor Appointments and UK Update

RSH Ann: Investor Presentation

RSH Ann: US FDA Clearance received

RSH Ann: Webinar and Q&A to be held tomorrow morning

RSH Ann: Trading Halt

RSH Ann: Investor Presentation - NWR conference

RSH Ann: Appendix 2A - exercise of options

RSH Ann: Proposed issue of Securities - RSH

RSH Ann: Respiri to present at NWR Comm.s Virtual Investor Conference

RSH Ann: Half Year Accounts

RSH Ann: Pharmacy Catalyst Members In-Pharmacy Asthma Mgt Program

RSH Ann: Change of Director's Interest Notice - TD

RSH Ann: Change of Director's Interest Notice - MM

RSH Ann: Change of Director's Interest Notice - NS

RSH Ann: Appendix 4C - quarterly

RSH Ann: Appendix 2A - exercise of options

RSH Ann: SuperChem to Commence Sales of wheezo

RSH Ann: Appendix 3G

RSH Ann: Proposed issue of Securities - RSH

RSH Ann: Results of Annual General Meeting

RSH Ann: CEO's Update at AGM

RSH Ann: Change of Director's Interest Notice - MM

RSH Ann: Change of Director's Interest Notice - NS

RSH Ann: New Partnership with Pharmacy 4 Less Banner Group

RSH Ann: Company Update Post Commercial Launch

RSH Ann: Michael Clarke Ambassador & Carlton AFLW co-sponsor

RSH Ann: Appendix 2A

RSH Ann: Notice of Annual General Meeting

RSH Ann: Manufacturing update

RSH Ann: wheezo Launch Update

RSH Ann: Patent application filed - Next Generation wheezo algorithm

RSH Ann: Appendix 2A

RSH Ann: Amended - Change in substantial holding

RSH Ann: Change in substantial holding

Register to track RSH and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
SOM